NFKB1 and HIV-1 infection: Notably, even in the absence of HIV-1 infection, SER5 significantly inhibits NF-κB activity induced by the key molecules involved in this signaling pathway in a dose-dependent manner (Figs. 2E and 5A) and markedly reduces the expression levels of several cytokines (Fig. 3).